IL-13Rα2 gene expression is a biomarker of adverse outcome in patients with adrenocortical carcinoma

• Abhinav Kumar,

  Roles Conceptualization, Data curation, Formal analysis, Writing – original draft, Writing – review & editing

  Affiliation Division of Cellular and Gene Therapies, Tumor Vaccines and Biotechnology Branch, Center for Biologics and Evaluation Research, US Food and Drug Administration, Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0003-3457-0215

  ⨯
• Ian H. Bellayr,

  Roles Conceptualization, Supervision, Writing – review & editing

  Current address: National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

  Affiliation Division of Cellular and Gene Therapies, Tumor Vaccines and Biotechnology Branch, Center for Biologics and Evaluation Research, US Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯
• Hridaya S. Singh,

  Roles Supervision, Writing – review & editing

  Affiliation Department of Zoology, Chaudhary Charan Singh University, Meerut, Uttar Pradesh, India

  ⨯
• Raj K. Puri

  Roles Conceptualization, Resources, Supervision, Writing – review & editing

  * E-mail: Raj.Puri@fda.hhs.gov

  Affiliation Division of Cellular and Gene Therapies, Tumor Vaccines and Biotechnology Branch, Center for Biologics and Evaluation Research, US Food and Drug Administration, Silver Spring, Maryland, United States of America

  https://orcid.org/0000-0003-2548-346X

  ⨯